Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, February 28, 2019
[ Thu, Feb 28th 2019
] - WOPRAI
[ Thu, Feb 28th 2019
] - WOPRAI
[ Thu, Feb 28th 2019
] - WOPRAI
[ Thu, Feb 28th 2019
] - WOPRAI
[ Thu, Feb 28th 2019
] - WOPRAI
[ Thu, Feb 28th 2019
] - WOPRAI
[ Thu, Feb 28th 2019
] - WOPRAI
[ Thu, Feb 28th 2019
] - WOPRAI
Wed, February 27, 2019
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
[ Wed, Feb 27th 2019
] - WOPRAI
Matthew Mishan Maintained (AVNS) at Buy with Decreased Target to $65 on, Feb 27th, 2019
Matthew Mishan of Keybanc, Maintained "Avanos Medical, Inc." (AVNS) at Buy with Decreased Target from $67 to $65 on, Feb 27th, 2019.
Matthew has made no other calls on AVNS in the last 4 months.
There is 1 other peer that has a rating on AVNS. Out of the 1 peers that are also analyzing AVNS, 0 agree with Matthew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Matthew
- Kristen Stewart of "Barclays" Downgraded from Hold to Sell and Decreased Target to $36 on, Friday, January 4th, 2019
Similar Stocks and Investing Articles
[ Tue, Feb 26th 2019
] - WOPRAI
[ Thu, Feb 14th 2019
] - WOPRAI
[ Mon, Feb 04th 2019
] - WOPRAI
[ Fri, Jan 04th 2019
] - WOPRAI
[ Tue, Dec 18th 2018
] - WOPRAI
[ Tue, Oct 16th 2018
] - WOPRAI
[ Tue, Feb 09th 2016
] - WOPRAI
[ Tue, Feb 09th 2016
] - WOPRAI
[ Thu, Feb 04th 2016
] - WOPRAI
[ Fri, Feb 27th 2015
] - WOPRAI